Apostle Inc is a biotechnology company and a provider of innovative technologies and services for public health and life sciences. The company owns and operates its headquarters at 3589 Nevada St, Pleasanton, CA 94566.
Apostle aims to develop best-in-class nucleic acid isolation and preservation technologies. Specifically, we aim to develop innovative technologies in the field of circulating free DNA (cfDNA), used in noninvasive prenatal testing (NIPT) and liquid biopsy - the sampling and analysis of non-solid biological tissue, primarily blood, often utilizing cfDNA as a biomarker. Our innovations include Apostle MiniMax, a best-in-class and automatable solution to efficiently capture cfDNA from a standard blood draw; Apostle MagTouch, a nucleic acids isolation automation system, and Apostle MiniEnrich, a high-resolution DNA size enrichment technology using a magnetic nano-platform.
In addition, Apostle also provides the MiniGenomics product series, providing efficient, scalable, and reproducible isolation of high-quality genomic DNA and/or RNA from a variety of biological specimens. The Apostle MiniGenomics product series has contributed significantly to the flight against COVID-19 during the recent pandemic.
Apostle technologies have been widely applied in many world-class R&D studies, clinical laboratory settings, and public health response and surveillance. These applications have resulted in many high-profile scientific publications including Nature Medicine, Nature Communications, Cancer Cell, Science Translational Medicine, PNAS, etc. To date, the company's products have served over 20 million people, while we are continuing to improve our technologies and products to further our mission to benefit public health and life sciences.
Apostle Inc is pleased to receive the Certificates of Conformance to certify that Quality Management System of Apostle Inc. has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by: ISO13485:2016, and ISO9001:2015. The Quality Management System is applicable to DEVELOPMENT, MANUFACTURING, LICENSING AND SALES OF CONSUMABLES AND CHEMICALS FOR NUCLEIC ACID RESEARCH. Apostle Inc holds a Medical Device Manufacturing License issued by State of California, Department of Public Health, Food and Drug Branch. In addition, Apostle Inc is also a clinical laboratory authorized by the US federal CLIA (CLIA ID 05D2191922), accredited by College of American Pathologists (CAP Number 8830916), with a Clinical and Public Health Laboratory License issued by the California state government. Click the images below to access the certificates and accreditations.
Apostle aims to develop best-in-class nucleic acid isolation and preservation technologies. Specifically, we aim to develop innovative technologies in the field of circulating free DNA (cfDNA), used in noninvasive prenatal testing (NIPT) and liquid biopsy - the sampling and analysis of non-solid biological tissue, primarily blood, often utilizing cfDNA as a biomarker. Our innovations include Apostle MiniMax, a best-in-class and automatable solution to efficiently capture cfDNA from a standard blood draw; Apostle MagTouch, a nucleic acids isolation automation system, and Apostle MiniEnrich, a high-resolution DNA size enrichment technology using a magnetic nano-platform.
In addition, Apostle also provides the MiniGenomics product series, providing efficient, scalable, and reproducible isolation of high-quality genomic DNA and/or RNA from a variety of biological specimens. The Apostle MiniGenomics product series has contributed significantly to the flight against COVID-19 during the recent pandemic.
Apostle technologies have been widely applied in many world-class R&D studies, clinical laboratory settings, and public health response and surveillance. These applications have resulted in many high-profile scientific publications including Nature Medicine, Nature Communications, Cancer Cell, Science Translational Medicine, PNAS, etc. To date, the company's products have served over 20 million people, while we are continuing to improve our technologies and products to further our mission to benefit public health and life sciences.
Apostle Inc is pleased to receive the Certificates of Conformance to certify that Quality Management System of Apostle Inc. has been assessed by ABS Quality Evaluations, Inc. and found to be in conformance with the requirements set forth by: ISO13485:2016, and ISO9001:2015. The Quality Management System is applicable to DEVELOPMENT, MANUFACTURING, LICENSING AND SALES OF CONSUMABLES AND CHEMICALS FOR NUCLEIC ACID RESEARCH. Apostle Inc holds a Medical Device Manufacturing License issued by State of California, Department of Public Health, Food and Drug Branch. In addition, Apostle Inc is also a clinical laboratory authorized by the US federal CLIA (CLIA ID 05D2191922), accredited by College of American Pathologists (CAP Number 8830916), with a Clinical and Public Health Laboratory License issued by the California state government. Click the images below to access the certificates and accreditations.
Current Accreditations
Recognitions and Awards
Team - Scientific Advisory Board
Team - Management
Apostle Diagnostics
